Aehr Test Systems (AEHR)
Official siteTECHNOLOGY • SEMICONDUCTOR EQUIPMENT & MATERIALS • NASDAQ
Market Cap: $1.87B
Last updated: Nov 17, 2026 at 11:05 AM ET
Aehr Test Systems (AEHR) Financials: Revenue, Profit and Cash Flow
Aehr Test Systems reported revenue of $50.00M for the fiscal year ended May 31, 2026, down 15.2% from the year before. That year, net income was -$7.13M with a net margin of -14.3%, operating cash flow was -$3.31M and free cash flow was -$5.38M. The quarter ended Sep 30, 2026 had revenue of $33.01M and net income of $7.18M.
Revenue and Margins
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| May 2026 | $50.00M | -15.2% | 35.3% | -28.3% | -14.3% |
| May 2025 | $58.97M | -10.9% | 40.6% | -9.6% | -6.6% |
| May 2024 | $66.22M | +1.9% | 49.1% | 15.2% | 50.1% |
| May 2023 | $64.96M | +27.8% | 50.4% | 20.6% | 22.4% |
| May 2022 | $50.83M | +206.2% | 46.6% | 15.3% | 18.6% |
| May 2021 | $16.60M | -25.5% | 36.3% | -25.2% | -12.2% |
| May 2020 | $22.29M | +5.9% | 37.6% | -12.4% | -12.6% |
| May 2019 | $21.06M | -28.8% | 36.1% | -23.7% | -24.9% |
| May 2018 | $29.55M | +56.4% | 41.9% | 3.1% | 1.8% |
| May 2017 | $18.90M | N/A | 35.9% | -26.1% | -29.9% |
Income Statement
Annual
| Line item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.00M | $58.97M | $66.22M | $64.96M | $50.83M | $16.60M | $22.29M | $21.06M | $29.55M | $18.90M |
| Cost of revenue | $32.35M | $35.03M | $33.67M | $32.22M | $27.16M | $10.57M | $13.92M | $13.45M | $17.17M | $12.12M |
| Gross profit | $17.65M | $23.93M | $32.54M | $32.75M | $23.66M | $6.03M | $8.37M | $7.60M | $12.39M | $6.78M |
| Research and development | $12.63M | $10.46M | $8.72M | $7.13M | $5.82M | $3.65M | $3.39M | $4.15M | $4.18M | $4.66M |
| Operating income | -$14.15M | -$5.68M | $10.08M | $13.38M | $7.80M | -$4.18M | -$2.77M | -$5.00M | $915.00K | -$4.93M |
| Net income | -$7.13M | -$3.91M | $33.16M | $14.56M | $9.45M | -$2.03M | -$2.80M | -$5.24M | $528.00K | -$5.65M |
| EBITDA | -$9.57M | -$2.30M | $11.30M | $13.89M | $10.57M | -$1.83M | -$2.39M | -$4.53M | $1.27M | -$4.53M |
Quarterly
| Line item | Sep 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.01M | $18.84M | $10.31M | $9.88M | $10.97M | $14.09M | $18.31M | $13.45M | $13.12M | $16.60M | $7.56M | $21.43M |
| Gross profit | $15.66M | $8.02M | $3.37M | $2.54M | $3.72M | $4.27M | $7.18M | $5.40M | $7.08M | $8.45M | $3.16M | $10.96M |
| Operating income | $6.05M | -$1.21M | -$4.23M | -$4.65M | -$4.07M | -$3.20M | -$1.12M | -$1.51M | $159.00K | $2.54M | -$2.05M | $5.47M |
| Net income | $7.18M | $1.39M | -$3.20M | -$3.23M | -$2.08M | -$2.90M | -$643.00K | -$1.03M | $660.00K | $23.86M | -$1.47M | $6.09M |
Balance Sheet
As of May 2026, cash and equivalents of $116.36M were 47.2% of total assets of $246.69M, against total liabilities of $27.18M.
Annual
| Line item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $246.69M | $148.51M | $127.91M | $98.14M | $62.33M | $21.66M | $20.57M | $21.31M | $30.95M | $30.89M |
| Current assets | $184.45M | $88.78M | $97.85M | $89.03M | $60.01M | $19.18M | $17.65M | $20.03M | $29.46M | $29.38M |
| Cash and equivalents | $116.36M | $24.53M | $49.16M | $30.05M | $31.48M | $4.58M | $5.43M | $5.43M | $16.85M | $17.80M |
| Total liabilities | $27.18M | $25.64M | $16.32M | $22.54M | $11.34M | $10.22M | $6.52M | $5.85M | $11.67M | $14.10M |
| Short-term debt | N/A | $909.00K | $465.00K | $137.00K | $794.00K | $3.08M | $653.00K | $0 | $6.11M | $0 |
| Long-term debt | N/A | N/A | N/A | N/A | N/A | $0 | $1.03M | $0 | $0 | $6.11M |
| Shareholder equity | $219.51M | $122.87M | $111.59M | $75.60M | $50.99M | $11.45M | $14.08M | $15.47M | $19.30M | $16.81M |
Quarterly
| Line item | Sep 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $258.78M | $246.69M | $157.05M | $148.73M | $144.09M | $148.51M | $145.61M | $142.28M | $145.86M | $127.91M | $101.60M | $101.17M |
| Total liabilities | $36.67M | $27.18M | $18.25M | $17.96M | $21.70M | $25.64M | $21.40M | $19.10M | $23.38M | $16.32M | $15.10M | $14.02M |
| Cash and equivalents | $104.90M | $116.36M | $36.91M | $30.84M | $22.71M | $25.23M | $29.41M | $32.22M | $37.83M | $49.16M | $47.58M | $50.51M |
| Shareholder equity | $222.11M | $219.51M | $138.79M | $130.78M | $122.39M | $122.87M | $124.21M | $123.18M | $122.48M | $111.59M | $86.50M | $87.15M |
Cash Flow
Annual
| Line item | May 2026 | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.31M | -$7.40M | $1.76M | $10.01M | $1.51M | -$2.70M | -$2.02M | -$5.64M | -$1.35M | -$4.50M |
| Capital expenditures | $2.07M | $4.99M | $749.00K | $1.36M | $416.00K | $227.00K | $163.00K | $173.00K | $572.00K | $477.00K |
| Free cash flow | -$5.38M | -$12.39M | $1.01M | $8.65M | $1.09M | -$2.93M | -$2.19M | -$5.81M | -$1.92M | -$4.97M |
| Dividends paid | N/A | N/A | N/A | N/A | $1.40M | $1.40M | $1.68M | N/A | $0 | $0 |
| Investing cash flow | -$3.87M | -$16.07M | $17.25M | -$18.66M | -$416.00K | -$227.00K | -$163.00K | -$173.00K | -$572.00K | -$477.00K |
| Financing cash flow | $97.21M | $625.00K | $139.00K | $7.32M | $25.76M | $1.96M | $2.17M | -$5.55M | $925.00K | $21.84M |
Quarterly
| Line item | Sep 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$3.05M | $1.83M | -$3.69M | -$1.17M | -$282.00K | -$2.30M | -$1.60M | -$5.87M | $2.38M | $1.22M | -$2.82M | -$545.00K |
| Capital expenditures | $49.00K | $134.00K | $74.00K | $467.00K | $1.39M | $2.82M | $1.66M | $321.00K | $197.00K | $46.00K | $263.00K | $156.00K |
| Free cash flow | -$3.10M | $1.70M | -$3.76M | -$1.64M | -$1.67M | -$5.12M | -$3.26M | -$6.19M | $2.18M | $1.18M | -$3.09M | -$701.00K |
Frequently Asked Questions About AEHR
What is Aehr Test Systems' annual revenue?
Aehr Test Systems reported revenue of $50.00M for the fiscal year ended May 31, 2026.
How fast is Aehr Test Systems' revenue growing?
Revenue was down 15.2% for the fiscal year ended May 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -8.4%.
Is Aehr Test Systems profitable?
No. Aehr Test Systems reported net income of -$7.13M for the fiscal year ended May 31, 2026, with a net margin of -14.3%.
How much free cash flow does AEHR generate?
For the fiscal year ended May 31, 2026, operating cash flow of -$3.31M minus capital expenditures of $2.07M produced free cash flow of -$5.38M.
How much debt does Aehr Test Systems have?
The balance sheet dated May 31, 2026 reported cash and equivalents of $116.36M.
AEHR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors